⌘K

Login Start Free

Home/Filings/4/0001209191-23-024937

4//SEC Filing

Kidron Miriam 4

Accession 0001209191-23-024937

CIK 0001176309other

View on SEC.gov Company Profile

Filed

Apr 19, 8:00 PM ET

Accepted

Apr 20, 6:00 AM ET

Size

5.0 KB

Accession

0001209191-23-024937

Insider Transaction Report

Form 4

Period: 2023-04-17

ORAMED PHARMACEUTICALS INC.ORMP

DirectorChief Scientific Officer

Transactions

Award
Common Stock
2023-04-17+213,000→ 414,666 total

Footnotes (1)

[F1]Represents Restricted Stock Units ("RSUs") that will vest in equal quarterly installments of 17,750 over a three year period starting May 1, 2023. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

ORAMED PHARMACEUTICALS INC.

CIK 0001176309

Entity typeother

Related Parties

1

filerCIK 0001409232

Filing Metadata

Form type: 4
Filed: Apr 19, 8:00 PM ET
Accepted: Apr 20, 6:00 AM ET
Size: 5.0 KB

View on SEC.gov